Exogenous expression of p16(INK4a) is associated with decrease in telomerase activity

Journal of Neuro-Oncology

Volumn 42, Issue 1, 1999, Pages 45-57

  Sawa, Hiroki ^a,c   Kamada, Hajime ^b   Ohshima, Teruyo Arato ^a   Noguchi, Akio ^a   Itoh, Nobuyuki ^a   Saruta, Kazuhiko ^a   Hara, Mitsuhiro ^a   Saito, Isamu ^a  

^a KYORIN UNIVERSITY   (Japan)

^b Hokuto Hospital   (Japan)

^c KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell cycle regulation; Glioma cell; p16(INK4a); Telomerase activity; Transfection

Indexed keywords

ECDYSONE; KI 67 ANTIGEN; MURISTERONE A; PROTEIN P16; TELOMERASE; UNCLASSIFIED DRUG; DRUG DERIVATIVE; ECDYSTERONE; PROTEIN P16INK4A; RECOMBINANT PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; CELL CYCLE; CELL GROWTH; CELL SHAPE; CELL SIZE; CELL STRUCTURE; CONTROLLED STUDY; DNA TRANSFECTION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; BRAIN TUMOR; CELL CLONE; CELL CULTURE; CELL DIVISION; DRUG EFFECT; GENETICS; METABOLISM; PATHOLOGY; PLASMID; SCANNING ELECTRON MICROSCOPY; ULTRASTRUCTURE;

BRAIN NEOPLASMS; CELL CYCLE; CELL DIVISION; CLONE CELLS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; ECDYSTERONE; GENE EXPRESSION REGULATION; GLIOBLASTOMA; HUMANS; MICROSCOPY, ELECTRON, SCANNING; PLASMIDS; RECOMBINANT PROTEINS; TELOMERASE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032587579     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006176708928     Document Type: Article

References (44)

1. Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707, 1993
2. Serrano M, Lee HW, Chin L, Gordon-Cardo C, Beach D, DePinho RA: Role of the INK4a locus in tumor suppression and cell mortality. Cell 85: 27-37,1996
3. Kamb A, Gruis NA, Weaver FJ, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day R III, Johnson BE, Skolnick MH: A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440, 1994
4. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753-756, 1994
5. Jen J, Harper JW, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Willson JKV, Kinzler KW, Vogelstein B: Deletion of p16 and p15 genes in brain tumors. Cancer Res 54: 6353-6358, 1994
6. He J, Allen JR, Collins VP, Allalunis-Turner MJ, Godbout R, Day RS. III, James CD: CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. Cancer Res 54: 5804-5808, 1994
7. INK4a expression is frequent in high grade gliomas. Cancer Res 55: 1941-1945, 1995
8. Sonoda Y, Yoshimoto T, Sekiya T: Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma. Oncogene 11: 2145-2149, 1995
9. Hall M, Peters G: Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res 68: 67-108, 1996
10. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE: Frequent somatic mutations and homozygous deletions of the p16 (MST1) gene in pancreatic adenocarcinoma. Nature Genet B: 27-32, 1994
11. INK4a in human cancer. Proc Natl Acad Sci USA 91: 11045-11049, 1994
12. Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, van Tornout JM, Jones PA: Methylation of the 5′CpG island of the p16/CDK2 tumor suppressor gene in normal and transformed human tissues correlates with gene splicing. Cancer Res 55: 4531-4535, 1995
13. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 cdk-interacting Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816, 1993
14. El-Deiry WS, Tokino T, Velculescu V, Levy DB, Kinzler KW, Vogelstein B: WAF1, a potential mediater of p53 tumor suppression. Cell 75: 817-825, 1993
15. INK4a/CDKN2 and cyclin D1 cooperate to deregulate G1 control. Cancer Res 55: 4818-4823, 1995
16. 16INK4a induced G1-S block. Cancer Res 56: 1719-1723, 1996
17. INK4a. Science 267: 249-252, 1995
18. Arap WA, Nishikawa R, Furunari FB, Cavenee WK, Huang HJS: Replacement of the p16/CDKN2 gene suppresses human glioma cell growth. Cancer Res 55: 1351-1354, 1995
19. Tenan M, Benedetti S, Finocchiaro G: Deletion and transfection analysis of the p15/MTS2 gene in malignant gliomas. Biochem Biophys Res Commun 217: 195-202, 1995
20. No D, Yao TP, Evans RM: Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci USA 93: 3346-3351, 1996
21. Hisatomi H, Nagao K, Komatsu H: Quantification of telomerase activity in human liver tissues by fluorescence-based TRAP analysis. Hepatology Res 7: 35-42, 1997
22. Kubota Y, Nakada T, Sasagawa I, Yanai H, Itoh K: Elevated levels of telomerase activity in malignant pheochromocytoma. Cancer 82: 176-179, 1998
23. Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD, Meyne J, Ratliff RL, Wu JR: A highly conserved repetitive sequence (TTAGGG)n, present at the telomeres of human chromosome. Proc Natl Acad Sci USA BS: 6622-6626, 1988
24. Harley CB, Futcher AB, Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460, 1990
25. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW: Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1: 249-255, 1995
26. Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S: Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 55: 3255-3262, 1995
27. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, Tahara E, Kajiyama G, Ide T: Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 55: 2734-2736, 1995
28. Langford LA, Piatyszek MA, Xu R, Schold SC Jr, Shay JW: Telomerase activity in human brain tumours. Lancet 346: 1267-1268, 1995
29. Key G, Becker MH, Baron B, Duchrow M, Schluter C, Flad HD, Gerdes J: New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 68: 629-636, 1993
30. Yabuki N, Sasano H, Kato K, Ohara S, Toyota T, Nagura H, Miyaike M, Nozaki N, Kikuchi A: Immunohistochemical study of DNA topoisomerase II in human gastric disorders. Am J Pathol 149: 997-1007, 1996
31. Walker DG, Duan W, Popovic EA, Kaye AH, Tomlinson FH, Lavin M: Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas. Cancer Res 55: 20-23, 1995
32. Moulton T, Samara G, Chung WY, Yuan L, Desai R, Sisti M, Bruce J, Tycko B: MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme. Am J Pathol 146: 613-619, 1995
33. Barker FG, Chen P, Furman F, Aldape KD, Edwards MSB, Israel MA: P16 deletion and mutation analysis in human brain tumors. J Neurooncol 31: 17-23, 1997
34. Dirks PB, Patel K, Hubbard SL, Ackerley C, Hamel PA, Rutka JT: Retinoic acid and the cyclin dependent kinase inhibitors synergistically alter proliferation and morphology of U343 astrocytoma cells. Oncogene 15: 2037-2048, 1997
35. INK4a. Oncogene 15: 505-514, 1997
36. INK4a. Biochem Biophys Res Commun 231: 743-750, 1997
37. Chintala SK, Fueyo J, Gomez-Manzano C, Venkaiah B, Bjerkvig R, Yung WKA, Sawaya R, Kyritsis AP, Rao JS: Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro. Oncogene 15: 2049-2057, 1997
38. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MB, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994
39. Zhu X, Kumar R, Mandal M, Sharma N, Sharma HW, Dhingra U, Sokoloski JA, Hsiao R, Narayanan R: Cell cycle dependent modulation of telomerase activity in tumor cells. Proc Natl Acad Sci USA 93: 6091-6095, 1996
40. Holt SE, Wright WE, Shay JW: Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 16: 2932-2939, 1996
41. Holt SE, Aisner DL, Shay JW, Wright WE: Lack of cell cycle regulation of telomerase activity in human cells. Proc Natl Acad Sci USA 94: 10687-10692, 1997
42. Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, Nakanishi T, Tahara E, Ide T, Ishikawa F: Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 18: 65-68, 1998
43. Nakayama J, Saito M, Nakamura H, Matsuura A, Ishikawa F: TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell 88: 875-884, 1997
44. Nakatani K, Yoshimi N, Mori H, Yoshimura S, Sakai H, Shinoda J, Sakai N: The significant role of telomerase activity in human brain tumors. Cancer 80: 471-476, 1997